<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Singh AT</submitter><funding>NIDDK NIH HHS</funding><funding>NIH</funding><funding>NIDDK</funding><funding>NIH HHS</funding><pagination>1203-1208</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9526807</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(11)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Hypertension is common in hemodialysis (HD) patients. Increased blood pressure (BP) variability, particularly higher and lower extremes, is associated with adverse outcomes. We explored the association of endothelin-1 (ET-1), a potent vasoconstrictor, with different BP parameters (pre-HD, intra-HD, and post-HD) during HD in a contemporary patient cohort.&lt;h4>Methods&lt;/h4>This study uses the DaVita Biorepository, a longitudinal prospective cohort study with quarterly collection of clinical data and biospecimens. Unadjusted and adjusted linear mixed effects regression models were fit to determine association of pre-HD ET-1 (log-transformed and quartiles) with HD-related systolic BP (SBP) parameters (pre-HD, nadir intra-HD, and post-HD). As ET-1 was measured at baseline, anal</pubmed_abstract><journal>American journal of hypertension</journal><pubmed_title>Endothelin-1 and Parameters of Systolic Blood Pressure in Hemodialysis.</pubmed_title><pmcid>PMC9526807</pmcid><funding_grant_id>K23DK102511</funding_grant_id><funding_grant_id>DK085660</funding_grant_id><funding_grant_id>U01DK096189</funding_grant_id><funding_grant_id>CA229772</funding_grant_id><funding_grant_id>R03DK122240</funding_grant_id><funding_grant_id>DK127587</funding_grant_id><pubmed_authors>Waikar SS</pubmed_authors><pubmed_authors>Mothi SS</pubmed_authors><pubmed_authors>Sabbisetti V</pubmed_authors><pubmed_authors>Li P</pubmed_authors><pubmed_authors>Singh AT</pubmed_authors><pubmed_authors>Mc Causland FR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Endothelin-1 and Parameters of Systolic Blood Pressure in Hemodialysis.</name><description>&lt;h4>Background&lt;/h4>Hypertension is common in hemodialysis (HD) patients. Increased blood pressure (BP) variability, particularly higher and lower extremes, is associated with adverse outcomes. We explored the association of endothelin-1 (ET-1), a potent vasoconstrictor, with different BP parameters (pre-HD, intra-HD, and post-HD) during HD in a contemporary patient cohort.&lt;h4>Methods&lt;/h4>This study uses the DaVita Biorepository, a longitudinal prospective cohort study with quarterly collection of clinical data and biospecimens. Unadjusted and adjusted linear mixed effects regression models were fit to determine association of pre-HD ET-1 (log-transformed and quartiles) with HD-related systolic BP (SBP) parameters (pre-HD, nadir intra-HD, and post-HD). As ET-1 was measured at baseline, anal</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-21T18:52:12.096Z</modification><creation>2025-04-05T17:26:22.638Z</creation></dates><accession>S-EPMC9526807</accession><cross_references><pubmed>34192305</pubmed><doi>10.1093/ajh/hpab104</doi></cross_references></HashMap>